Lataa...
PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
(1) Background: Niraparib and Talazoparib are poly (ADP-ribose) polymerase (PARP) 1/2 inhibitors. It is assumed that combining PARP inhibitors with radiotherapy could be beneficial for cancer treatment. In this study, melanoma cells were treated with Niraparib and Talazoparib in combination with ion...
Tallennettuna:
| Julkaisussa: | Genes (Basel) |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8229922/ https://ncbi.nlm.nih.gov/pubmed/34073147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12060849 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|